Coronavirus Update: Moderna's Vaccine Frontrunner Gets Fast-Tracked, Wuhan To Test Millions
Plus China Tighthens Biosafety Standards, Aimmune Pauses Launch
Moderna gets green light to proceed to Phase II trial of mRNA vaccine, with its eagerly-awaited Phase I results expected shortly.